今日上市：海圣医疗

Core Viewpoint - Haisheng Medical (920166) has been listed on the Beijing Stock Exchange, focusing on the development, production, and sales of anesthesia and monitoring medical devices, which are widely used in various clinical departments [1][2]. Company Overview - Haisheng Medical is a global provider of comprehensive products in the anesthesia and monitoring medical device sector, with its main business activities centered around the R&D, production, and sales of these medical devices [2]. - The company’s products are extensively applied in departments such as anesthesiology, ICU, and emergency medicine [2]. Shareholding Structure - Prior to the issuance, Huang Haisheng directly held 47.11% of the company's shares, making him the controlling shareholder. His spouse, Wu Xiaoye, holds a 20.60% stake in Lixin Investment, which indirectly controls 7.81% of the company’s shares [2]. - Together, Huang Haisheng and Wu Xiaoye control a total of 54.92% of the company's shares, confirming their status as the actual controllers of Haisheng Medical [2]. Fundraising Details - The total amount raised from this issuance is approximately 142.76 million yuan, with a net amount of about 113.44 million yuan [2]. - The raised funds are intended for upgrading and expanding production of anesthesia and monitoring emergency medical devices, establishing a R&D testing center, and building a marketing service base [2].